NL-OMON49661已完成3 期
An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090 - FIREFLEYE Next
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Subjects are eligible to be included in the study only if the following
- •criteria apply: 1.Subject was treated in Study 20090, 2.Age less than 13 months
- •of chronological age, 3.Signed informed consent from parent(s)/legally
- •authorized representative(s) as described in Section 10.1.3 of the clinical
- •trial protocol, which includes compliance with the requirements and
- •restrictions listed in the informed consent form (ICF) and in the protocol
排除标准
- •Subjects are excluded from the study if the following criterion applies:
- •Medical Conditions, 1. Subject has a condition preventing participation in the
- •study, or performance of study procedures
研究者
相似试验
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurityEUCTR2018-003180-54-ESBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurityEUCTR2018-003180-54-GBBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-HUBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1Level: PTClassification code 10038933Term: Retinopathy of prematuritySystem Organ Class: 10015919 - Eye disordersRetinopathy of prematurityEUCTR2018-003180-54-ROBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-PTBayer AG102